Literature DB >> 7869358

Early helper T-cell dysfunction in simian immunodeficiency virus but not in human immunodeficiency virus type-2-infected macaques.

U Dittmer1, W Lüke, C Stahl-Hennig, C Coulibaly, H Petry, W Bodemer, G Hunsmann, G Voss.   

Abstract

Both naive and vaccinated macaques acquired a virus-specific proliferative helper T-cell reactivity in response to infection with the nonpathogenic human immunodeficiency virus type 2 (HIV-2). In contrast, macaques infected with the pathogenic simian immunodeficiency virus of the macaque strain (SIVmac) did not develop a helper T-cell response. Furthermore, a vaccine-induced preexisting T-cell reactivity was abrogated after SIVmac infection in vaccine failures. These differences may reflect the different pathogenicity of the two closely related viruses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7869358     DOI: 10.1111/j.1600-0684.1994.tb00287.x

Source DB:  PubMed          Journal:  J Med Primatol        ISSN: 0047-2565            Impact factor:   0.667


  3 in total

1.  Comparative interleukin (IL-2)/interferon IFN-gamma and IL-4/IL-10 responses during acute infection of macaques inoculated with attenuated nef-truncated or pathogenic SICmac251 virus.

Authors:  O Benveniste; B Vaslin; R Le Grand; A Cheret; F Matheux; F Theodoro; M P Cranage; D Dormont
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

2.  Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and beta-chemokine production.

Authors:  M C Gauduin; R L Glickman; S Ahmad; T Yilma; R P Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

3.  Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239.

Authors:  David T Evans; Jennifer E Bricker; Hannah B Sanford; Sabine Lang; Angela Carville; Barbra A Richardson; Michael Piatak; Jeffrey D Lifson; Keith G Mansfield; Ronald C Desrosiers
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.